Magnetar Financial LLC Ionis Pharmaceuticals Inc Transaction History

Magnetar Financial LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$33.58 - $41.2 $367,533 - $450,934	-10,945 Reduced 31.64%	23,652 $845,000
Q4 2022 Feb 14, 2023	BUY	$37.12 - $46.52 $1.28 Million - $1.61 Million	34,597 New	34,597 $1.31 Million
Q2 2021 Aug 06, 2021	SELL	$34.54 - $47.25 $271,657 - $371,621	-7,865 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$42.51 - $63.78 $602,536 - $904,017	-14,174 Reduced 64.31%	7,865 $354,000
Q4 2020 Feb 12, 2021	BUY	$45.3 - $60.27 $998,366 - $1.33 Million	22,039 New	22,039 $1.25 Million

408

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.73B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Magnetar Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Magnetar Financial LLC with notifications on news.